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OBJECTIVE—To investigate pedometer-measured physical activity (PA) in 2000 and change
in PA over 5 years with subsequent risk of dysglycemia by 2005.
RESEARCH DESIGN AND METHODS—This prospective cohort study in Tasmania,
Australia, analyzed 458 adults with normal glucose tolerance and a mean (SD) age of 49.7 (12.1)
years in 2000. Variables assessed in 2000 and 2005 included PA, by pedometer and question-
naire, nutrient intake, and other lifestyle factors. Incident dysglycemia was deﬁned as the de-
velopment of impaired fasting glucose or impaired glucose tolerance revealed by oral glucose
tolerance testing in 2005, without type 2 diabetes.
RESULTS—Incident dysglycemia developed in 26 participants during the 5-year period.
Higher daily steps in 2000 were independently associated with a lower 5-year risk of incident
dysglycemia (adjusted odds ratio [AOR] 0.87 [95% CI 0.77–0.97] per 1,000-step increment).
Higher daily steps in 2005, after controlling for baseline steps in 2000 (thus reﬂecting change in
steps over 5 years), were not associated with incident dysglycemia (AOR 1.02 [0.92–1.14]).
Higher daily steps in 2000 were also associated with lower fasting blood glucose, but not 2-h
plasma glucose by 2005. Further adjustment for BMI or waist circumference did not remove
these associations.
CONCLUSIONS—Among community-dwelling adults, a higher rate of daily steps is associ-
ated with a reduced risk of incident dysglycemia. This effect appears to be not fully mediated
through reduced adiposity.
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T
he number of people with type 2
diabetes will escalate from 285 to
438million between 2010and 2030
(1). Preventive strategies targeting modi-
ﬁable factors, such as physical activity
(PA), are a priority. Current public health
policyislimitedbyaninabilitytoquantify
the magnitude of the apparent beneﬁcial
effect of PA due to a lack of studies
measuring PA objectively and incident
dysglycemia. Incident dysglycemia in-
cludes individuals who newly develop
impaired fasting glucose (IFG) but who
have a normal response to a glucose
load, and/or individuals with a normal
fasting glucose but impaired glucose tol-
erance (IGT) (2). Incident dysglycemia is
associated with increased risk of type 2
diabetes, cardiovascular disease, and
death (3–6).
Althoughevidenceisemergingthatthe
increasing prevalence of type 2 diabetes
and its precursor, dysglycemia, is partly
attributed to a physically inactive lifestyle,
few prospective studies have used objec-
tively measured PA to evaluate this associ-
ation. Two recent cohort studies reported
conﬂicting ﬁndings regarding the associa-
tions of accelerometer-measured moderate
and vigorous activity with insulin resis-
tance (7,8).
A review conducted predominantly in
individualsathigherriskofdiabetes,witha
mean (SD) fasting blood glucose of 7.09
(2.09) mmol/L at baseline, reported that
pedometer-measured PA was not associ-
ated with fasting glucose level (b 20.03
mmol/L; P = 0.70) (9). The lack of an asso-
ciation could be explained by 1) the rela-
tively small sample size in these studies (a
pooled sample of 211 participants), 2)t h e
interventionlengthandfollow-upbeingin-
sufﬁcient to assess longer-term metabolic
change, or 3) nondetection of a glucose
metabolic effect that the oral glucose toler-
ance test (OGTT) would have detected.
We have recently reported that lower
daily steps at baseline and a reduction in
daily steps by follow-up are both associ-
ated with impaired insulin sensitivity at a
5-year follow-up (10). Here, we examine
the longitudinal association between PA
(using pedometer-measured and self-
reported activity) and incident dysglyce-
mia, deﬁned by repeated OGTT in the
population-based Australian Diabetes,
Obesity and Lifestyle Study (AusDiab).
RESEARCH DESIGN AND
METHODS
Study population
The AusDiab is a large population-based
study designed to investigate the national
prevalence of diabetes and related risk
factors in 2000 (11,12). Baseline testing
was conducted in 2000, and the study
recruited 11,247 adults aged $25 years,
with .85% being born in Australia, New
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ORIGINAL ARTICLEZealand, or the U.K. In the state of
Tasmania, AusDiab included six random
census collection districts based on the
1996 Australian Census. Of those who
completed a questionnaire, 40% partici-
pated in the physical examination. An
OGTT was administered at baseline and
at follow-up, unless the participants were
pregnant or being treated with oral hypo-
glycemic medication. Of 1,611 partici-
pants who had a baseline OGTT result,
592 provided 2-day pedometer data at
baseline and at follow-up (10,13). Of
these, we excluded 38 who had impaired
fasting glucose (IFG) and 75 who had im-
paired glucose tolerance (IGT) on the ba-
sis of their initial OGTT, and we further
excluded 2 who developed type 2 diabe-
tesat follow-upand19with no follow-up
glycemic status data. Thus, 458 partici-
pants were available for the assessment
of incident dysglycemia and 460 for the
assessment of type 2 diabetes.
The study was approved by the In-
ternational Diabetes Institute Ethics Com-
mittee and the Human Research Ethics
Committee of the University of Tasmania.
Informed consent was obtained from all
participants.
Study measures
Participants were invited to attend a local
testing site where physical measurements
and a fasting venous blood sample were
obtained at baseline and follow-up.
Questionnaire assessment of recent
PA time
Information on the frequency and dura-
tion of PA in the previous week was
collected using the Active Australia Ques-
tionnaire (14). A weighted sum of the re-
sponses (with vigorous-intensity activity
given double-weighting) was calculated
to quantify total hours of PA (14).
Objective pedometer assessment
of PA
The pedometer (Omron HJ-003 and
Omron HJ-102; Omron Healthcare, Inc.,
Bannockburn, IL) protocol has been pre-
viously described (10,13). Pedometer
data were collected for 2 consecutive
days in 2000, and only readings that in-
cluded at least 1 weekday were used. In
2005, participants were asked to wear
pedometers during weekdays and week-
ends for 7 consecutive days. To provide
comparability with the 2000 pedometer
measures, only the ﬁrst 2 consecutive
days of the 2005 pedometer measures
were used where at least 1 day was a
weekday (10,13). The intraclass correla-
tions are 0.71–0.84 for any 2 days of re-
cording (15). Pedometers are simpler and
cheaper than accelerometers and thus
have been generally more applicable in
large population-based studies. Although
accelerometers provide information about
pattern, intensity, and type of PA, which
willnotallbecapturedbypedometers,the
intraclass correlation coefﬁcient relating
their step measures has been estimated at
0.74 to 0.86 for 7 days of recording (16).
Diet, other lifestyle, and
demographic attributes
We collected self-reported information on
current smoking status (deﬁned as current
or past/never) and education level (#12
years vs. .12 years). A self-administered
validated food frequency questionnaire,
developed by the Cancer Council of Victo-
ria, was used to assess dietary and alcohol
intake during the previous 12 months at
both phases based on the Nutrient Data
Table for Use in Australia 1995 (11).
Physical examination
Heightwasmeasuredtothenearest0.5 cm
without shoes,and weightwas recorded to
the nearest 0.1 kg. Waist circumference
was measured halfway between the lower
border of the ribs and the iliac crest on the
horizontal plane. BMI (kg/m
2) and waist
circumference were used as adiposity
measures (11,12).
Fasting plasma glucose and 2-h
plasma glucose
Fasting blood samples were collected and
centrifuged on site and transported daily
to the central laboratory. Serum insulin
(samples stored at 280°C) was measured
using a human insulin–speciﬁcr a d i o -
immunoassay kit (Linco Research,
St. Charles, MO) for participants aged
.35yearsin2000,andachemilumines-
cence method was used for all partici-
pants in 2005 (12). We assessed OGTT
in both phases. Fasting plasma glucose
(FPG) levels were determined using
an Olympus AU600 automated ana-
lyzer (Center Valley, PA) in 2000 and
spectrophotometric-hexokinase methods
(Roche Diagnostics, Indianapolis, IN) in
2005 (12).
IFG, IGT, or type 2 diabetes were
deﬁned according to 1999 World Health
Organization diabetes criteria. Participants
who reported a history of physician-
diagnosed diabetes and who were receiv-
ing treatment with oral hypoglycemic
agents and/or insulin, or had a fasting
plasma glucose (FPG) level $7.0 mmol/L
or 2-h plasma glucose (2-hPG) level
$11.1 mmol/L were classiﬁed as having
type 2 diabetes. Participants who did not
havediabeteswereclassiﬁedashaving(in
mmol/L) IFG (FPG $6.1 and ,7.0, with
2-hPG ,7.8), IGT (2-hPG $7.8 and
,11.1,withFPG,7.0),ornormalglucose
tolerance (FPG ,6.1 and 2-hPG ,7.8).
Statistical analysis
The primary outcome of interest was
incident dysglycemia, deﬁned as partic-
ipants who had no dysglycemia or type 2
diabetes at baseline who had developed
IFG or IGT—but not type 2 diabetes—by
the 5-year follow-up. Type 2 diabetes was
excluded in our main analyses because
this reﬂects a different disease end point
and the numbers were too small to study
type 2 diabetes alone. We also, however,
used a secondary outcome with an ex-
panded deﬁnition to also incorporate
the two individuals with type 2 diabetes.
Because previous studies have reported
different pathophysiologic processes
may underlie the etiology of IFG and
IGT, we also used FPG and 2-hPG levels
at follow-up as continuous outcome var-
iables, enabling exploration in a parallel
analysis.
Categoric variables aredescribed using
percentagesandcontinuousvariablesusing
meansandSDormediansandinterquartile
ranges, if not normally distributed. Using
logistic regression models, we examined
the prospective association between base-
line PA and glucose metabolism in 2005,
without adjusting for follow-up PA (17).
To assess change of PA in relation to dys-
glycemia, PA in 2000 and 2005 were both
included in the logistic regression model.
Insuchamodel,theoddsratio(OR)forPA
in 2005 could therefore be interpreted as
the OR for change in activity after 5 years
becausebaselineactivitywasincluded(18).
A range of potential confounders
measured in 2000 were considered in
model building. We used relatedness of
potential confounders to exposures and
outcomes and change-in-estimate crite-
riontoselectpotentialconfoundersinthe
multivariable model. We investigated
whether the effect of daily steps on dys-
glycemia was mediated through reduced
adiposity by additionally adjusting for
BMI or waist circumference in 2000 and
2005. We also examined change in PA in
other ways by using a categoric ordinal
variable (13). We classiﬁed daily steps
into ﬁve categories: persistent low steps
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Physical activity and incident dysglycemia(the lowest third tertile of daily steps in
both 2000 and 2005), decreasing steps
(dropped by one or two categories be-
tween2000and2005),persistentmoder-
ate steps (middle third at both waves),
increasing steps (increase of one or two
categories), and persistent high steps
(highest third at both waves).
In a sensitivity analysis, population-
weightedmodels wereﬁtted to determine
whether the results were inﬂuenced by
differences on demographic characteris-
tics between the 458 participants ana-
lyzed in this report and those who were
excluded. Weights were used to adjust
the analyzed sample to be representative
of the reference group (all Tasmanian
AusDiab participants at baseline, exclud-
ing those with dysglycemia/type 2 diabe-
tes) with respect to sex and age, BMI in
2000, and socioeconomic status. The
weights were the inverse of the probabil-
ity of being analyzed in this report and
were calculated using the probabilities
obtained after ﬁtting a logistic regression
ofwhetheranalyzedinthisreport(0=not
analyzed; 1 = analyzed) compared with
thereferencegroup(19).WeusedSTATA
11 software (StataCorp, College Station,
TX) for all analyses.
RESULTS—The mean (SD) age of the
study sample was 49.7 (12.1) years at
baseline with 55.9% women. Of the 458
people free of type 2 diabetes or dysgly-
cemia at baseline, dysglycemia had de-
veloped in 26 (5.7%) by follow-up.
Among these, 11 (42.3%) were classiﬁed
as IFG and 15 (57.7%) as IGT. Type 2 di-
abetes developed in a further 2. At base-
line, the median number (interquartile
range) of daily steps was 10,733 (7,695–
13,833). Median change in daily steps
over 5 years was 21,469 (25,068 to
1,315). Median self-reported PA in the
past week at baseline was 4 (1–8) h and
medianself-reportedvigorousactivitywas
0( 0 –1) h. Participants who developed
dysglycemiawereolder,weremorelikely
to be men, had a larger waist circumfer-
ence, were more overweight, and were
less likely to smoke (Table 1).
Higher baseline daily steps were as-
sociatedwithlowerincidentdysglycemia,
after adjusting for age and sex (adjusted
OR [AOR] 0.87 [95% CI 0.77–0.97] per
1,000-step increment, Table 2). The in-
dependent association of higher daily
stepsatbaselinewithlowerriskofdysgly-
cemia remained unchanged after addi-
tionally adjusting for BMI at baseline
and follow-up (AOR 0.87 [0.78–0.98])
or waist circumference (0.88 [0.79–
0.99]). Change in daily steps over 5 years
was not associated with incident dysgly-
cemia, after adjusting for baseline daily
steps, age, and sex (AOR 1.02 [0.92–
1.14]). Neither self-reported baseline PA
nor self-reported change in PA was asso-
ciated with incident dysglycemia (data
not shown).
An inverse linear relationship was
found between daily steps at baseline
and 5-year FPG and 2-hPG. Fractional
polynomial modeling (20) was used to
assess any departure from linearity, and
indicated the linear model was appro-
priate. In the multivariable analysis, a
1,000-step increment at baseline was sig-
niﬁcantly associated with a 0.01 mmol/L
(95% CI 20.018 to 20.003, P = 0.006)
lower 5-year FPG, after adjusting for age
andsex(Table3).Theassociationofbase-
line daily steps with 5-year FPG was
partly attenuated after further controlling
for BMI at baseline and follow-up (b
20.008 [95% CI 20.016 to 20.001],
P = 0.03) or baseline and follow-up waist
circumference (b 20.007 [20.015 to
20.000], P = 0.06). Again, change in
daily steps was not associated with 5-
year FPG. Neither baseline daily steps
nor change in step activity was associated
with the 5-year 2-hPG.
Overall, self-reported PA was not
associated with 5-year FPG or 2-hPG.
Change in self-reported vigorous activity
over 5 years was positively associated
with lower 5-year 2-hPG (b 20.001
[95% CI 20.002 to 20.000] mmol/L,
P = 0.04), after adjusting for baseline
self-reported vigorous activity, age, and
sex. This association was substantially at-
tenuated and became nonsigniﬁcant after
further adjustment for BMI at baseline
and follow-up (b 20.0006 [20.002 to
0.000] mmol/L, P = 0.21), indicating the
associationbetweenchangeinself-reported
vigorous activity and 2-hPG may be partly
mediated through the associated beneﬁcial
reduction in adiposity.
The additional individual adjustment
for family history of diabetes; socioeco-
nomic status; current smoking (ciga-
rettes/day); alcohol (g/day), total energy
(kJ/day), protein (g/day), carbohydrate
Table 1—Baseline characteristics comparing participants who did and did not develop
5-year incident dysglycemia
Incident dysglycemia
Did not develop Developed
Variable n =4 3 2 n =2 6
Age (years) 49.4 (0.6) 54.9 (2.3)
Women (%) 56.7 (245/432) 42.3 (11/26)
Waist circumference (cm) 86.7 (0.6) 92.9 (2.0)
Weight (kg) 74.2 (0.7) 80.7 (3.2)
Height (cm) 168.6 (0.4) 170.9 (2.1)
BMI (kg/m
2) 26.0 (0.2) 27.4 (0.6)
Weight class by BMI (kg/m
2)
Overweight, .25 to ,30 (%) 43.0 (185/430) 69.2 (18/26)
Obese, $30 (%) 14.7 (63/430) 15.4 (4/26)
Current cigarette smoking (%) 12.9 (55/427) 3.9 (1/26)
Alcohol consumption (g/day)* 6.3 (0.8–16.8) 8.0 (0.9–23.2)
Data show crude mean (SD), proportions (n/N), or *median (interquartile range).
Table 2—Relationship of pedometer-measured PA with 5-year incident dysglycemia
Variable
Unadjusted Adjusted
OR (95% CI) P OR (95% CI) P
Daily steps (1,000 steps/day)
Baseline 0.85 (0.76–0.95) 0.004 0.87 (0.77–0.97)* 0.01
Follow-up 1.01 (0.91–1.12)† 0.87 1.02 (0.92–1.14)‡ 0.65
*Multivariablemodelforbaselinedailystepsadjustedforageandsex.†Adjustedforbaselinedailystepsasthe
crude model for follow-up activity (reﬂecting change in activity). ‡Multivariable model for follow-up daily
steps (reﬂecting change in activity) adjusted for baseline daily steps, age, and sex.
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Ponsonby and Associates(g/day), or fat intake (g/day) collected at
baselinedidnotalterthemagnitudeofthe
association between daily steps in 2000
and incident dysglycemia by more than
3% (Table 2). Similarly, the associations
reported in Table 3 were not altered by
further adjustment for these factors. Fur-
thermore, inclusion of the two partici-
pants with type 2 diabetes as additional
dysglycemia cases did not alter the ﬁnd-
ings in Tables 2 and 3. For this expanded
classiﬁcation of dysglycemia (type 2 dia-
betes,IFG,andIGT),higher daily steps in
2000 remained independently associated
with a lower 5-year risk of incident dys-
glycemia (AOR 0.86 [95% CI 0.77–0.96]
per1,000-stepincrement),afteradjusting
for age and sex. Higher daily steps in
2005, after controlling for baseline steps
in 2000 (thus reﬂecting change in steps
over 5 years), were also not associated
with this expanded classiﬁcation of dys-
glycemia(AOR1.00[0.90–1.11]).Higher
daily steps in 2000 were also associated
with lower FPG (P = 0.003), but not
2-hPG by 2005 (P = 0.15). When change
in PA was analyzed using a categoric ordi-
nal variable, participants with persistent
low daily steps in both 2000 and 2005
were signiﬁcantly more likely to have inci-
dent dysglycemia by 2005 (AOR 2.98
[1.27–6.97]) than those who did not.
There was no signiﬁcant variation in risk
across the other categories of activity (test
of trend, P = 0.30). The associations be-
tween 1) higher baseline daily steps and
risk of dysglycemia or between 2)h i g h e r
baseline steps and FPG were altered little
byaccounting for the nonresponsebias us-
ing inverse probability weighting.
CONCLUSIONS—Thisstudyprovides
the ﬁrst evidence, to our knowledge, that
objectivelymeasuredhigherPAisassociated
with reduced risk of dysglycemia over
5years.Inaparallelanalysis,usingblood
glucose measures as an outcome with a
continuous scale, higher baseline daily
steps remained an independentpredictor
of lower FPG levels 5 years later.
The strengths of the study include its
population-based sample, prospective de-
sign, objective pedometer measurement of
PA,longfollow-up,useofrepeatedOGTTs
to accurately classify glycemic status, and
the collection of a variety of potential
confounders. The associations observed
are prospective, but the timing of the in-
cident occurrence is unavailable. The ex-
posuremeasure,however,wasdailystepsat
baseline,andbecauseglycemicstatusrather
than overt diabetes was the focus, partic-
ipants would be likely to be asymptomatic
and unaware of their conditions and, thus,
would be less likely to modify factors, such
as adiposity, by follow-up.
The number ofincidentcaseswasnot
large. However, similar patterns were
observed in the parallel analysis using
daily steps in 2000 and continuous glu-
cose measures in 2005. The small case
numberandlowmagnitudeofanychange
in PA,with an average decline ofless than
1,500 steps, may explain the lack of
association between a change in daily
steps and dysglycemia risk. We were
able to address the issue of loss to follow-
up in this cohort study by weighting the
results for the loss that occurred. This did
not affect the estimate of association be-
tweendailystepsanddysglycemia.Finally,
wecannotfullyruleoutresidualconfound-
ing due to unmeasured confounders (e.g.,
genetic factors) or potentially misclassiﬁed
measures.
Previous data from the AusDiab have
shown that 1) self-reported PA is associ-
ated with a reduced prevalence of im-
paired glucose metabolism (21) and
2) inactivity is associated with an
increased incidence of type 2 diabetes
(12). Some studies have demonstrated a
rapid short-term effect of PA on fasting in-
sulin and glucose concentration (22,23).
Results from this current study suggest
that PA may also have a relatively longer-
term effect on glucose metabolism. Studies
for direct comparison are not available at
present, although a recent review showed
littleeffectofinterventionstoincreasedaily
steps on FPB concentration (9).
The reason higher daily steps was
associated with incident dysglycemia
here, but not in the studies included in
thereview(9),maybethatPAhasalonger-
term effect on dysglycemia, which was re-
ﬂected by PA in 2000 but not PA in 2005
being associated with dysglycemia, and
that persistently low average daily steps
had the highest risk. Alternatively, the
use of repeated OGTTs here may have
provided more sensitive detection. Also,
most studies included in the review were
conducted among highly selected groups.
Furthermore, our ﬁnding that PA, when
measured objectively rather than self-
reported, was associated with subsequent
dysglycemiaandFPGlevels,togetherwith
the previous report that a lower magni-
tude of association was observed for the
prospective association between self-
report PA and insulin sensitivity (10), in-
dicates that objective measures such as
pedometers may capture PA better by in-
clusion of incidental activity and reduced
measurement error.
We estimated that every increment of
1,000 daily steps resulted in a 13% lower
odds of 5-year incident dysglycemia. In
the parallel analysis, an inverse associa-
tion remains between baseline daily steps
and 5-year FPG. For this later association
the beneﬁcial changes may be partly
mediated through a reduced BMI or waist
circumference. A similar result was
Table 3—Relationships of pedometer-measured PA with 5-year FPG and 2-hPG
Outcome Unadjusted Adjusted*
Variable Mean difference (95% CI) P Mean difference (95% CI) P
FPG
Daily steps, 1,000-step increase/day
Baseline 20.011 (20.019 to 20.004) 0.004 20.01 (20.018 to 20.003)* 0.006
Follow-up 0.004 (20.006 to 0.013)† 0.45 0.004 (20.006 to 0.013)‡ 0.46
2-hPG
Daily steps, 1,000-step increase/day
Baseline 20.021 (20.043 to 0.001) 0.06 20.014 (20.036 to 0.008)* 0.22
Follow-up 20.005 (20.033 to 0.023)† 0.72 0.003 (20.025 to 0.031)‡ 0.84
*Multivariable model for baseline daily steps adjusted for age and sex. †Adjusted for baseline daily steps in this crude model for follow-up daily steps (thus reﬂects
change in activity). ‡Multivariable model for follow-up daily steps (thus reﬂects change in activity) adjusted for baseline daily steps, age, and sex.
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Physical activity and incident dysglycemiaobserved when waist circumference was
used as an alternative adiposity measure.
Our data are consistent with a recent
systematic review that revealed that higher
self-reported PA is associated with lower
risk of type 2 diabetes, even after account-
ingforBMI(BMI-adjustedrelativerisk0.83
[95% CI 0.76–0.90]) (24). Findings from
this current study add to the broader evi-
dencebaseontheimportanceofincreasing
PA through its direct beneﬁcial effect on
future glucose metabolism.
The ﬁndings here of a signiﬁcant asso-
ciation between daily steps in 2000 and
incident dysglycemia are consistent with a
recent report from the same cohort that
daily steps in 2000 were associated with
improved insulin sensitivity in 2005 (10).
Althoughourpreviousstudydemonstrated
that an increase indaily steps in2000 com-
pared with 2005 was associated with im-
proved insulin sensitivity (10), this current
study did not show that it was associated
with areductionintherisk ofincidentdys-
glycemia, raising the possibility that PA
has a longer-term effect on dysglycemia
thaninsulinsensitivity.Inaddition,thecur-
rentﬁndingssuggestthatanincreaseinself-
reported vigorous activity over 5 years may
have a different effect on aspects of glucose
metabolism than daily steps alone.
This study has allowed us to quantify
the magnitude of the effect. An increase
frombeingessentiallysedentarytomeeting
the goal of 10,000 steps (25)—a 10,000-
step increase—would be associated with
76%loweroddsofdevelopingdysglycemia
5 years later, based on the magnitude of
associations observed in this study (AOR
0.24 [95% CI 0.08–0.73]). Alternatively,
from any average daily steps, an additional
2,000 steps would be associated with a
25% reduction in developing incident
dysglycemia over the subsequent 5 years
(AOR 0.75 [0.60–0.94] per 2,000 steps).
Our ﬁndings indicate that if the type 2
diabetes cases were additionally included
in an expanded deﬁnition of dysglycemia,
a similar magnitude of effect would be
expected.
To conclude, higher daily steps is an
important predictor of a lower 5-year risk
of dysglycemia among an adult popula-
tion, and such an effect appears to be not
fully mediated by reduced adiposity.
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